DBV Technologies | DBVT - Pre Tax Profit

Stock Price
21.26
Daily Change
-0.20 -0.93%
Monthly
18.18%
Yearly
416.02%
Q1 Forecast
21.05

DBV Technologies reported $-33.16M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 44.6M 4.38M Sep/2025
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
Amarin USD -8.12M 5.34M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
DBV Technologies USD -33.16M 8.6M Sep/2025
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Incyte USD 482.31M 75.7M Sep/2025
Insmed USD -368.7M 48.26M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Neurocrine Biosciences USD 291.8M 132.3M Sep/2025
PTC Therapeutics USD -23.07M 47.98M Sep/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
Ultragenyx Pharmaceutical USD -179.54M 65.54M Sep/2025
United Therapeutics USD 438M 29.6M Sep/2025